Fertility in female cancer survivors: Pathophysiology, preservation and the role of ovarian reserve testing

Human Reproduction Update

Volumn 11, Issue 1, 2005, Pages 69-89

  Singh, Kerryn Lutchman ^a   Davies, Melanie ^a   Chatterjee, Ratna ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cancer; Chemotherapy; Fertility; Ovarian reserve tests; Premature menopause

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BIOLOGICAL MARKER; CLOMIFENE CITRATE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTRADIOL; ESTROGEN RECEPTOR; FLUOROURACIL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; INHIBIN B; LUTEINIZING HORMONE; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

ACCURACY; AGE; AMENORRHEA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; CRYOPRESERVATION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY MENOPAUSE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GEOGRAPHIC DISTRIBUTION; GONAD; GONADORELIN TEST; GYNECOLOGICAL EXAMINATION; HUMAN; INFERTILITY THERAPY; OOCYTE MATURATION; ORGAN PRESERVATION; ORGAN SIZE; OUTCOMES RESEARCH; OVARY BLOOD FLOW; OVARY CANCER; OVARY FOLLICLE; OVARY FUNCTION; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; REVIEW;

BIOLOGICAL MARKERS; CRYOPRESERVATION; EMBRYO; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTES; OVARY; PREGNANCY; TISSUE PRESERVATION; ULTRASONOGRAPHY;

EID: 13444272139     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/dmh052     Document Type: Review

References (264)

1. Andolf E, Jorgensen C, Svalenius E and Sunden B (1987) Ultrasound measurement of the ovarian volume. Acta Obstet Gynecol Scand 66,387-389.
2. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP and Grootegoed JA (1995) Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle and gonadotropin-induced follicle growth. Endocrinology 136,4951-4962.
3. Baird DT, Webb R, Campbell BK, Harkness LM and Gosden RG (1999) Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at - 196 C. Endocrinology 140,462-471.
4. Bancsi LF, Broekmans FJ and te Velde ER (1997) Predictive value of serum inhibin-B for ART outcome? Fertil Steril 68,947-948.
5. Bancsi LF, Huijs AM, den Ouden CT, Broekmans FJ, Looman CW, Blankenstein MA and te Velde ER (2000) Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 73,552-557.
6. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD and te Velde ER (2002) Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77,328-336.
7. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD and te Velde ER (2003) Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79,1091-1100.
8. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2004) Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril 81,35-41.
9. Barnhart K and Osheroff J (1998) Follicle stimulating hormone as a predictor of fertility. Curr Opin Obster Gynecol 10,227-232.
10. Barnhart K and Osheroff J (1999) We are overinterpreting the predictive value of serum follicle-stimulating hormone levels. Fertil Steril 72,8-9.
11. Bath LE, Wallace WH and Critchley HO (2002) Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br J Obster Gynaecol 109,107-114.
12. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C and Anderson RA (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18,2368-2374.
13. Beckers NG, Macklon NS, Eijkemans MJ and Fauser BC (2002) Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 78,291-297.
14. Bedaiwy MA and Falcone T (2004) Ovarian tissue banking for cancer patients: reduction of post-transplantation ischaemic injury: intact ovary freezing and transplantation. Hum Reprod 19,1242-1244.
15. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362,419-427.
16. Bines J, Oleske DM and Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14,1718-1729.
17. Blumenfeld Z (2002) Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers. Mol Cell Endocrinol 18,93-105.
18. Blumenfeld Z (2003) Gynaecologic concerns for young women exposed to gonadoroxic chemotherapy. Curr Opin Obstet Gynecol 15,359-370.
19. Blumenfeld Z, Avivi I, Ritter M and Rowe JM (1999) Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest 6,229-239.
20. Brown JR, Modell E, Obasaju M and King YK (1996) Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast. Hum Reprod 11,197-199.
21. Bukman A and Heineman MJ (2001) Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 7,581-590.
22. Bukulmez O and Arici A (2004) Assessment of ovarian reserve. Curr Opin Obster Gynecol 16,231-237.
23. Burger HG (1999) The endocrinology of the menopause. J Steroid Biochem Mol Biol 69,31-35.
24. Burger HG, Groome NP and Robertson DM (1998) Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 83,4167-4169.
25. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A and Dennerstein L (1999) Prospectively measured levels of serum follicle-stimulating hormone, estradiol and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84,4025-4030.
26. Buyalos RP, Daneshmand S and Brzechffa PR (1997) Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy. Fertil Steril 68,272-277.
27. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB and Meigs JW (1992) Early menopause in long-term survivors of cancer during adolescence. Am J Obster Gynecol 166,788-793.
28. Cahill DJ, Fox R and Thomas PH (1992) Spurious elevation of follicle-stimulating hormone. Acta Obster Gynecol Scand 71,388-389.
29. Casper FW, Seufert RJ, Schaffrath M and Pollow K (2001) Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment. Fertil Steril 75,32-37.
30. Chang MY, Chiang CH, Chiu TH, Hsieh TT and Soong YK (1998a) The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program. J Assist Reprod Genet 15,12-17.
31. Chang MY, Chiang CH, Hsieh TT, Soong YK and Hsu KH (1998b) Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 69,505-510.
32. Chatterjee R and Goldstone AH (1996) Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 17,5-11.
33. Chatterjee R and Kottaridis PD (2002) Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplant 30,629-635.
34. Chatterjee R, Mills W, Katz M, McGarrigle HH and Goldstone AH (1994) Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant 13,511-517.
35. Chen C (1986) Pregnancy after human oocyte cryopreservation. Lancet 1(8486),884-886.
36. Chian RC, Lim JH and Tan SL (2004) State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 16,211-219.
37. Christensen JT, Boldsen J and Westergaard JG (1997) Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand 76,784-789.
38. Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN and Yang YS (2003) Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril 79,63-68.
39. Chui DK, Pugh ND, Walker SM, Gregory L and Shaw RW (1997) Follicular vascularity - the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod 12,191-196.
40. Clayton RN and Huhtaniemi IT (1982) Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature 299,56-59.
41. Cook CL, Siow Y, Taylor S and Fallat ME (2000) Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73,859-861.
42. Corson SL, Gutmann J, Batzer FR, Wallace H, Klein N and Soules MR (1999) Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod 14,2818-2821.
43. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA and Balasch J (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15,2341-2346.
44. Crofton PM, Thomson AB, Evans AE, Groome NP, Bath LE, Kelnar CJ and Wallace WH (2003) Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer? Clin Endocrinol (Oxf) 58,296-301.
45. Csemiczky G, Harlin J and Fried G (2002) Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta Obster Gynecol Scand 81,954-961.
46. de Boer EJ, Den TI, te Velde ER, Burger CW and Van Leeuwen FE (2003) Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18,1544-1552.
47. de Koning CH Popp-Snijders C, Martens F and Lambalk CB (2000a) Falsely elevated follicle-stimulating hormone levels in women with regular menstrual cycles due to interference in immunoradiometric assay. J Assist Reprod Genet 17,457-459.
48. de Koning CH, Popp-Snijders C, Schoemaker J and Lambalk CB (2000b) Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude, response to GnRH. Hum Reprod 15,1452-1456.
49. De Sutter P and Dhont M (2003) Poor response after hormonal stimulation for in vitro fertilization is not related to ovarian aging. Fertil Steril 79,1294-1298.
50. de Vet A, Laven JS, de Jong FH, Themmen AP and Fauser BC (2002) Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77,357-362.
51. Del Mastro L, Venturini M, Sertoli MR and Rosso R (1997) Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Res Treat 43,183-190.
52. Dnistrian AM, Schwartz MK, Fracchia AA, Kaufman RJ, Hakes TB and Currie VE (1983) Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients. Cancer 51,803-807.
53. Dnistrian AM, Greenberg EJ, Dillon HJ, Hakes TB, Fracchia AA and Schwartz MK (1985) Chemohormonal therapy and endocrine function in breast cancer patients. Cancer 56,63-70.
54. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B and Van Langendonckt A (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443),1405-1410.
55. Dowsett M and Richner J (1991) Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients. Oncology 48,215-220.
56. Dumesic DA, Damario MA, Session DR, Famuyide A, Lesnick TG, Thornhill AR and McNeilly AS (2001) Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. J Clin Endocrinol Metab 86,2538-2543.
57. Durlinger AL, Visser JA and Themmen AP (2002) Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124,601-609.
58. Dzik A, Lambert-Messerlian G, Izzo VM, Scares JB, Pinotti JA and Seifer DB (2000) Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 74,1114-1117.
59. Eldar-Geva T, Robertson DM, Cahir N, Groome N, Gabbe MP, Maclachlan V and Healy DL (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Clin Endocrinol Metab 85,607-613.
60. Eldar-Geva T, Margalioth EJ, Ben Chetrit A, Gal M, Robertson DM, Healy DL, Diamant YZ and Spitz IM (2002) Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 17,2331-2337.
61. El Toukhy T, Khalaf Y, Hart R, Taylor A and Braude P (2002) Young age does not protect against the adverse effects of reduced ovarian reserve- an eight year study. Hum Reprod 17,1519-1524.
62. Elting MW, Kwee J, Schats R, Rekers-Mombarg LT and Schoemaker J (2001) The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab 86,1589-1595.
63. Engmann L, Sladkevicius P, Agrawal R, Bekir JS, Campbell S and Tan SL (1999) Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril 71,22-29.
64. Erdem M, Erdem A, Gursoy R and Biberoglu K (2004) Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF. J Assist Reprod Genet 21,37-45.
65. Esposito MA, Coutifaris C and Barnhart KT (2002) A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women. Hum Reprod 17,118-123.
66. Evers JL, Slaats P, Land JA, Dumoulin JC and Dunselman GA (1998) Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril 69,1010-1014.
67. Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S and Flamigni C (2001) Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod 16,411-416.
68. Fabregues F, Balasch J, Creus M, Carmona F, Puerto B, Quinto L, Casamitjana R and Vanrell JA (2000) Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome. J Assist Reprod Genet 17,13-19.
69. Faddy MJ and Gosden RG (1996) A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11,1484-1486.
70. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ and Nelson JF (1992) Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7,1342-1346.
71. Falcone T, Attaran M, Bedaiwy MA and Goldberg JM (2004) Ovarian function preservation in the cancer patient. Fertil Steril 81,243-257.
72. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A and Frydman R (1994) Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod 9,1607-1611.
73. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R and Taieb J (2003a) Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18,328-332.
74. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R and Taieb J (2003b) Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol FSH and, L.H. on day 3. Hum Reprod 18,323-327.
75. Farhi J, Homburg R, Ferber A, Orvieto R and Ben Rafael Z (1997) Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 12,241-243.
76. Fawzy M, Lambert A, Harrison RF, Knight PG, Groome N, Hennelly B and Robertson WR (2002) Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod 17,1535-1543.
77. Ficicioglu C, Kutlu T, Demirbasoglu S and Mulayim B (2003) The role of inbibin B as a basal determinant of ovarian reserve. Gynecol Endocrinol 17,287-293.
78. Findlay JK (1986) Angiogenesis in reproductive tissues. J Endocrinol 111,357-366.
79. Flaws JA, Rhodes JC, Langenberg P, Hirshfield AN, Kjerulff K and Sharara FI (2000) Ovarian volume and menopausal status. Menopause 7,53-61.
80. Flaws JA, Langenberg P, Babus JK, Hirshheld AN and Sharara FI (2001) Ovarian volume and antral follicle counts as indicators of menopausal status. Menopause 8,175-180.
81. Forbes JF (1992) Long-term effects of adjuvant chemotherapy in breast cancer. Acta Oncol 31,243-250.
82. Frattarelli JL, Bergh PA, Drews MR, Sharara FI and Scott RT (2000) Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril 74,518-524.
83. Frattarelli JL, Levi AJ, Miller BT and Segars JH (2003) A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril 80,350-355.
84. Fried G, Remaeus K, Harlin J, Krog E, Csemiczky G, Aanesen A and Tally M (2003) Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet 20,167-176.
85. Friedlander M and Thewes B (2003) Counting the costs of treatment: the reproductive and gynaecological consequences of adjuvant therapy in young women with breast cancer. Intern Med J 33,372-379.
86. Galtier-Dereure F, De BV, Picto MC, Vergnes C, Humeau C, Bringer J and Hedon B (1996) Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: correlation with in-vitro fertilization outcome. Hum Reprod 11,1393-1398.
87. Ganz PA (2000) Quality of life across the continuum of breast cancer care. Breast J 6,324-330.
88. Ganz PA and Greendale GA (2001) Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy. J Clin Oncol 19,3303-3305.
89. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M and Hood N (1999) Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17,2365-2370.
90. Gosden RG (1987) Follicular status at the menopause. Hum Reprod 2, 617-621.
91. Gosden RG, Baird DT, Wade JC and Webb R (1994) Restoration of fertility to oophorectomized sheep by ovarian autografts stored at - 196 degrees C. Hum Reprod 9,597-603.
92. Gosden RG, Mullan J, Picton HM, Yin H and Tan SL (2002) Current perspective on primordial follicle cryopreservation and culture for reproductive medicine. Hum Reprod Update 8,105-110.
93. Gougeon A, Ecochard R and Thalabard JC (1994) Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod 50,653-663.
94. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP and McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81,1401-1405.
95. Gruijters MJ, Visser JA, Durlinger AL and Themmen AP (2003) Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 211,85-90.
96. Gulekli B, Bulbul Y, Onvural A, Yorukoglu K, Posaci C, Demir N and Erten O (1999) Accuracy of ovarian reserve tests. Hum Reprod 14,2822-2826.
97. Hall JE, Welt CK and Cramer DW (1999) Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14,409-415.
98. Hankey BF, Miller B, Curtis R and Kosary C (1994) Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 16,7-14.
99. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A and Laufer N (1998) Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril 69,1001-1004.
100. Hansen KR, Morris JL, Thyer AC and Soules MR (2003) Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril 80,577-583.
101. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP and Gocial B (1996) Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 11,486-489.
102. Hensley ML and Reichman BS (1998) Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Crit Rev Oncol Hematol 28,121-128.
103. Hershlag A, Lesser M, Montefusco D, Lavy G, Kaplan P, Liu HC and Rosenfeld D (1992) Interinstitutional variability of follicle-stimulating hormone and estradiol levels. Fertil Steril 58,1123-1126.
104. Higgins RV, van NJ, Jr, Woods CH, Thompson EA and Kryscio RJ (1990) Interobserver variation in ovarian measurements using transvaginal sonography. Gynecol Oncol 39,69-71.
105. Hofmann GE, Sosnowski J, Scott RT and Thie J (1996) Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 66,49-53.
106. Hofmann GE, Danforth DR and Seifer DB (1998) Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 69,474-477.
107. Hreinsson JG, Otala M, Fridstrom M, Bergstrom B, Rasmussen C, Lundqvist M, Tuuri T, Simberg N, Mikkola M, Dunkel L and Hovatta O (2002) Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab 87,3618-3623.
108. Hsieh YY, Chang CC and Tsai HD (2001) Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation. J Assist Reprod Genet 18,320-324.
109. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB and MacLaughlin DT (1990) An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. I Clin Endocrinol Metab 70,16-22.
110. 2, or pH, predict oocyte developmental competence in in vitro fertilization. Fertil Steril 72,707-712.
111. Ivarsson SA, Nilsson KO and Persson PH (1983) Ultrasonography of the pelvic organs in prepubertal and postpubertal girls. Arch Dis Child 58,352-354.
112. Jarvela IY, Sladkevicius P, Kelly S, Ojha K, Campbell S and Nargund G (2003a) Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol 102,816-822.
113. Jarvela IY, Sladkevicius P, Tekay AH, Campbell S and Nargund G (2003b) Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 21, 277-282.
114. Jatoi I and Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4,251-254.
115. Johnson J, Canning J, Kanedo T, Pru JK and Tilly JL (2004a) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Obstet Gynecol Surv 59,518-520.
116. Johnson J, Canning J, Kaneko T, Pru JK and Tilly JL (2004b) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428,145-150.
117. Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A et al. (2002) Goserelin versus cyclophosphamide, meLhotrexate and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol 20,4628-4635.
118. Josso N, Racine C, Di Clemente N, Rey R and Xavier F (1998) The role of anti-Mullerian hormone in gonadal development. Mol Cell Endocrinol 145,3-7.
119. Kim YK, Wasser SK, Fujimoto VY, Klein NA, Moore DE and Soules MR (1997) Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol and FSH:LH ratio in predicting reproductive age in normal women. Hum Reprod 12,1152-1155.
120. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ and Soules MR (1996a) Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 81,1038-1045.
121. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE and Soules MR (1996b) Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81,2742-2745.
122. Klinkert ER, Broekmans FJ, Looman CW and te Velde ER (2004) A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 81,1247-1253.
123. Koyama H, Wada T, Nishizawa Y, Iwanaga T and Aoki Y (1977) Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 39,1403-1409.
124. Kupesic S (2001) The present and future role of three-dimensional ultrasound in assisted conception. Ultrasound Obstet Gynecol 18,191-194.
125. Kupesic S and Kurjak A (2002) Predictors of IVF outcome by three-dimensional ultrasound. Hum Reprod 17,950-955.
126. Kupesic S, Kurjak A, Bjelos D and Vujisic S (2003) Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 79,190-197.
127. Kwee J, Elting MW, Schats R, Bezemer PD, Lambalk CB and Schoemaker J (2003) Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 18,1422-1427.
128. Kwee J, Schats R, McDonnell J, Lambalk CB and Schoemaker J (2004) Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 19,590-595.
129. Lambalk CB (2003) Value of elevated basal follicle-stimulating hormone levels and the differential diagnosis during the diagnostic subfertility work-up. Fertil Steril 79,489-490.
130. Lambalk CB, Boomsma DI, De Boer L, de Koning CH, Schoute E, Popp-Snijders C and Schoemaker J (1998) Increased levels and pulsatility of follicle-stimulating hormone in mothers of hereditary dizygotic twins. JClin.Endocrinol.Metab 83,481-486.
131. Lambalk CB, de Koning CH, Flett A, Van Kasteren Y, Gosden R and Homburg R (2004) Assessment of ovarian reserve. Ovarian biopsy is not a valid method for the prediction of ovarian reserve. Hum Reprod 19,1055-1059.
132. Larsen EC, Muller J, Rechnitzer C, Schmiegelow K and Andersen AN (2003a) Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10IU/l. Hum Reprod 18,417-422.
133. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C and Andersen AN (2003b) Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88,5307-5314.
134. Lashen H, Ledger W, Lopez-Bernal A and Barlow D (1999) Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14,964-969.
135. Lass A (2001) Assessment of ovarian reserve - is there a role for ovarian biopsy? Hum Reprod 16,1055-1057.
136. Lass A (2004) Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data? Hum Reprod 19,467-469.
137. Lass A and Brinsden P (1999) The role of ovarian volume in reproductive medicine. Hum Reprod Update 5,256-266.
138. Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R and Winston RM (1997a) Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod 12,1028-1031.
139. Lass A, Skull J, McVeigh E, Margara R and Winston RM (1997b) Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 12,294-297.
140. Laven JS, Mulders AG, Visser JA, Themmen AP, de Jong FH and Fauser BC (2004) Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89,318-323.
141. Lawson R, El Toukhy T, Kassab A, Taylor A, Braude P, Parsons J and Seed P (2003) Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 18,527-533.
142. Lee DM, Yeoman RR, Battaglia DE, Stouffer RL, Zelinski-Wooten MB, Fanton JW and Wolf DP (2004) Live birth after ovarian tissue transplant. Nature 428,137-138.
143. Lee SJ, Lenton EA, Sexton L and Cooke ID (1988) The effect of age on the cyclical patterns of plasma LH FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3,851-855.
144. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT and Scott RT, Jr (2001) Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 76,666-669.
145. Licciardi FL, Liu HC and Rosenwaks Z (1995) Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64,991-994.
146. Lobo RA (2003) Early ovarian ageing: a hypothesis. What is early ovarian ageing? Hum Reprod 18,1762-1764.
147. Lockwood GM, Muttukrishna S, Groome NP, Matthews DR and Ledger WL (1998) Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 83,1730-1735.
148. Lockwood GM, Muttukrishna S and Ledger WL (1998) Inhibins and activins in human ovulation, conception and pregnancy. Hum Reprod Update 4,284-295.
149. Long WQ, Ranchin V, Pautier P, Belville C, Denizot P, Cailla H, Lhomme C, Picard JY, Bidart JM and Rey R (2000) Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85,540-544.
150. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M and Thomas K (1990) Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 53,295-301.
151. Lower EE, Blau R, Gazder P and Tummala R (1999) The risk of premature menopause induced by chemotherapy for early breast cancer. J. Women's Health Gend Based Med 8,949-954.
152. McDonough PG (2003) Ovarian reserve-drawing distinctions between the quality and numbers of oocytes. Fertil Steril 80,673-674.
153. McVie JG (1999) Cancer treatment: the last 25 years. Cancer Treat Rev 25,323-331.
154. Mehta RR, Beattie CW and Das Gupta TK (1992) Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 20,125-132.
155. Meirow D (2000) Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 169,123-131.
156. Meirow D and Nugent D (2001) The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 7,535-543.
157. Meirow D, Lewis H, Nugent D and Epstein M (1999) Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 14,1903-1907.
158. Mettlin C (1999) Global breast cancer mortality statistics. CA Cancer J Clin 49,138-144.
159. Mikkelsen AL, Andersson AM, Skakkebaek NE and Lindenberg S (2001) Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women. Hum Reprod 16,862-867.
160. Moore HC (2000) Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer. Curr Oncol Rep 2,587-593.
161. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS and Rosenwaks Z (1988) The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50,298-307.
162. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M and Grunfeld L (1996) An elevated day three follicle-stimulating hormone: luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65,588-593.
163. Muscari LE, Aikin JL and Good BC (1999) Premature menopause after cancer treatment. Cancer Pract 7,114-121.
164. Muttukrishna S and Knight PG (1990) Effects of crude and highly purified bovine inhibin (Mr 32, 000 form) on gonadotrophin production by ovine pituitary cells in vitro: inhibin enhances gonadotrophin-releasing hormone-induced release of LH. J Endocrinol 127,149-159.
165. Muttukrishna S and Knight PG (1991) Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro. J Mol Endocrinol 6,171-178.
166. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR and Knight PG (1994) Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 9,1634-1642.
167. Muttukrishna S, Child T, Lockwood GM, Groome NP, Barlow DH and Ledger WL (2000) Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum Reprod 15,549-556.
168. Nahum R, Shifren JL, Chang Y, Leykin L, Isaacson K and Toth TL (2001) Antral follicle assessment as a tool for predicting outcome in IVF - is it a better predictor than age and FSH? JAssist Reprod Genet 18,151-155.
169. Nargund G, Bourne T, Doyle P, Parsons J, Cheng W, Campbell S and Collins W (1996) Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality. Hum Reprod 11,109-113.
170. Nasir J, Walton C, Lindow SW and Masson EA (1997) Spontaneous recovery of chemotherapy-induced primary ovarian failure: implications for management. Clin Endocrinol (Oxf) 46,217-219.
171. Navot D, Rosenwaks Z and Margalioth EJ (1987) Prognostic assessment of female fecundity. Lancet 2(8560),645-647.
172. Ng EH, Tang OS and Ho PC (2000) The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum Reprod 15,1937-1942.
173. Ng EH, Yeung WS, Fong DY and Ho PC (2003) Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod 18,2169-2174.
174. Nikolaou D and Templeton A (2003) Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 18,1137-1139.
175. Nikolaou D, Lavery S, Turner C, Margara R and Trew G (2002) Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 17,1106-1111.
176. Nystedt M, Berglund G, Bolund C, Fornander T and Rutqvist LE (2003) Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 21,1836-1844.
177. Office for National Statistics (2004) Office for National Statistics. Cancer Survival trends in England and Wales, 1971-1995: deprivation and, N.H.S Region. Series SMPS No 61
178. Oktay K and Karlikaya G (2000) Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342,1919.
179. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L and Rosenwaks Z (2003) Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 18,90-95.
180. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M and Rosenwaks Z (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363,837-840.
181. Padilla SL, Bayati J and Garcia JE (1990) Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 53,288-294.
182. Pan HA, Cheng YC, Li CH, Wu MH and Chang FM (2002) Ovarian stroma flow intensity decreases by age: a three-dimensional power doppler ultrasonographic study. Ultrasound Med Biol 28,425-430.
183. Parker SL, Tong T, Bolden S and Wingo PA (1997) Cancer statistics, 1997. CA Cancer J Clin 47,5-27.
184. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A and Winer EP (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22,4174-4183.
185. Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ and van NJ, Jr (2000) Ovarian volume related to age. Gynecol Oncol 77,410-412.
186. Pellicer A, Lightman A, Diamond MP, Russell JB and DeCherney AH (1987) Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 47,812-815.
187. Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C and Bonilla-Musoles F (1998) Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 70,671-675.
188. Penarrubia J, Balasch J, Fabregues F, Carmona F, Casamitjana R, Moreno V, Calafell JM and Vanrell JA (2000) Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod 15,1499-1504.
189. Perez MM, Gromoll J, Behre HM, Gassner C, Nieschlag E and Simoni M (2000) Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85,3365-3369.
190. Pohl M, Hohlagschwandtner M, Obruca A, Poschalko G, Weigert M and Feichtinger W (2000) Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet 17,315-318.
191. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L and Jouannet P (2002) Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod 17,1447-1452.
192. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O and Hamigni C (1997) Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 68,724-726.
193. Posada MN, Kolp L and Garcia JE (2001) Fertility options for female cancer patients: facts and fiction. Fertil Steril 75,647-653.
194. Radford JA, Lieberman BA, Brison DR, Smith AR, Critchlow JD, Russell SA, Watson AJ, Clayton JA, Harris M, Gosden RG and Shalet SM (2001) Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet 357, 1172-1175.
195. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL and Skakkebaek NE (1999) Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84,3836-3844.
196. Ranieri DM, Quinn F, Makhlouf A, Khadum I, Ghutmi W, McGarrigle H, Davies M and Serhal P (1998) Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 70,227-233.
197. Ranieri DM, Phophong P, Khadum I, Meo F, Davis C and Serhal P (2001) Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF. Hum Reprod 16,673-675.
198. Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G and Winston R (2000) Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod 15,2297-2301.
199. Revel A and Schenker J (2004) Ovarian tissue banking for cancer patients: is ovarian cortex cryopreservation presently justified? Hum Reprod 19,14-19.
200. Richardson SJ, Senikas V and Nelson JF (1987) Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65,1231-1237.
201. Roberts VJ, Barth S, el Roeiy A and Yen SS (1993) Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 77,1402-1410.
202. Robertson JA (2000) Ethical issues in ovarian transplantation and donation. Fertil Steril 73,443-446.
203. Rose DP and Davis TE (1977) Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet 1(8023),1174-1176.
204. Rostom AY (2001) The management of menopausal sequelae in patients with breast cancer. Clin Oncol (R Coll Radiol) 13,174-180.
205. Ruess ML, Kline J, Santos R, Levin B and Timor-Tritsch I (1996) Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 174,624-627.
206. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, Van Lint MT, Powles R, Jackson G, Hinterberger-Fischer M, Kolb HJ and Apperley JF (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358,271-276.
207. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, Witherspoon RP and Thomas ED (1988) Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 6,813-818.
208. Santoro NA, del T and Skurnick JH (1999) Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71,658-662.
209. Scheffer GL Broekmans FJ, Dorland M, Habbema JD, Looman CW and te Velde ER (1999) Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72,845-851.
210. Scheffer GJ, Broekmans FL Bancsi LF, Habbema JD, Looman CW and te Velde ER (2002) Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 20,270-275.
211. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, te Jong FH and te Velde ER (2003) The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18,700-706.
212. Schipper I, de Jong FH and Fauser BC (1998) Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Hum Reprod 13,1442-1448.
213. Schmidt KL, Byskov AG, Nyboe AA, Muller J and Yding AC (2003) Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod 18,1158-1164.
214. Schover LR (1999) Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review. Med Pediatr Oncol 33,53-59.
215. Schover LR, Rybicki LA, Martin BA and Bringelsen KA (1999) Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 86,697-709.
216. Scott RT Jr (2004) Diminished ovarian reserve and access to care. Fertil Sterd 81,1489-1492.
217. Scott RT Jr and Hofmann GE (1995) Prognostic assessment of ovarian reserve. Fertil Steril 63, 1-11.
218. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S and Rosenwaks Z (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51,651-654.
219. Scott RT Jr, Hofmann GE, Oehninger S and Muasher SJ (1990) Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 54,297-302.
220. Scott RT Jr, Illions EH, Kost ER, Dellinger C, Hofmann GE and Navot D (1993) Evaluation of the significance of the estradiol response during the clomiphene citrate challenge test. Fertil Steril 60,242-246.
221. Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH and Navot D (1995) Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 10,1706-1710.
222. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS and Berk CA (1997) Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril 67,110-114.
223. Seifer DB, Scott RT, Jr, Bergh PA, Abrogast LK, Friedman CI, Mack CK and Danforth DR (1999) Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 72,63-65.
224. Seifer DB, MacLaughlin DT, Christian BP, Feng B and Shelden RM (2002) Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77,468-471.
225. Shapiro CL, Manola J and Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19,3306-3311.
226. Sharara FI and McClamrock HD (1999) The effect of aging on ovarian volume measurements in infertile women. Obstet Gynecol 94,57-60.
227. Sharara FI and Scott RT (2004) Assessment of ovarian reserve. Is there still a role for ovarian biopsy? First do no harm! Hum Reprod 19,470-471.
228. Sharara FI, Scott RT, Jr and Seifer DB (1998) The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 179,804-812.
229. Sharif K, Elgendy M, Lashen H and Afnan M (1998) Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol 105,107-112.
230. Shaw JM, Bowles J, Koopman P, Wood EC and Trounson AO (1996) Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 11,1668-1673.
231. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL and Stillman RJ (1995) Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64,1136-1140.
232. Sonmezer M and Oktay K (2004) Fertility preservation in female patients. Hum Reprod Update 10,251-266.
233. Soules MR, Battaglia DE and Klein NA (1998) Inhibin and reproductive aging in women. Maturitas 30,193-204.
234. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ and Fujimoto S (2002) Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 8,893-899.
235. Sutton R, Buzdar AU and Hortobagyi GN (1990) Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 65,847-850.
236. Syrop CH, Willhoite A and Van Voorhis BJ (1995) Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril 64,1167-1171.
237. Syrop CH, Dawson JD, Husman KJ, Sparks AE and Van Voorhis BJ (1999) Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod 14,1752-1756.
238. Tanbo T, Dale PO, Lunde O, Norman N and Abyholm T (1992) Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 57,819-824.
239. te Velde ER (1993) Disappearing ovarian follicles and reproductive ageing. Lancet 341,1125-1126.
240. te Velde ER and Pearson PL (2002) The variability of female reproductive ageing. Hum Reprod Update 8,141-154.
241. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ and Fauser BC (1998) Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol 145,67-73.
242. Thomson AB, Critchley HO, Kelnar CJ and Wallace WH (2002) Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 16,311-334.
243. Tilly JL (2003) Ovarian follicle counts - not as simple as 1, 2, 3. Reprod Biol Endocrinol 1,11.
244. Tinkanen H, Blauer M, Laippala P, Tuohimaa P and Kujansuu E (1999) Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril 72,932-936.
245. Tinkanen H, Blauer M, Laippala P, Tuohimaa P and Kujansuu E (2001) Correlation between serum inhibin B and other indicators of the ovarian function. Eur J Obstet Gynecol Reprod Biol 94,109-113.
246. Tomas C, Nuojua-Huttunen S and Martikainen H (1997) Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 12,220-223.
247. Toner JP (2003) Age = egg quality, FSH level = egg quantity. Fertil Steril 79,491.
248. Toner JP (2004) Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify. Fertil Steril 81, 1493-1495.
249. Toner JP, Philput CB, Jones GS and Muasher SJ (1991) Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 55,784-791.
250. Tong S, Wallace EM and Burger HG (2003) Inhibins and activins: clinical advances in reproductive medicine. Clin Endocrinol (Oxf) 58,115-127.
251. Treloar AE (1981) Menstrual cyclicity and the pre-menopause. Maturitas 3,249-264.
252. Van der Elst J (2003) Oocyte freezing: here to stay? Hum Reprod Update 9,463-470.
253. Van Montfrans JM, Hoek A, Van Hooff MH, de Koning CH, Tonch N and Lambalk CB (2000) Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertil Steril 74,97-103.
254. van Rooij IA, Brockmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH and Themmen AP (2002) Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
255. van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2003) Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 79,482-488.
256. van Rooij IA, de Jong E, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2004) High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril 81,1478-1485.
257. Wallace WH and Kelsey TW (2004) Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 19,1612-1617.
258. Wang X, Chen H, Yin H, Kim SS, Lin TS and Gosden RG (2002) Fertility after intact ovary transplantation. Nature 415,385.
259. Warne GL, Fairley KF, Hobbs JB and Martin FI (1973) Cyclophosphamide-induced ovarian failure. N Engl J Med 289,1159-1162.
260. Welt CK (2002) The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14,317-323.
261. Winslow KL, Toner JP, Brzyski RG, Ochninger SC, Acosta AA and Muasher SJ (1991) The gonadotropin-releasing hormone agonist stimulation test-a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 56,711-717.
262. Yanushpolsky EH, Hurwitz S, Tikh E and Racowsky C (2003) Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertil Steril 80,111-115.
263. Yong PY, Baird DT, Thong KJ, McNeilly AS and Anderson RA (2003) Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 18,35-44.
264. Zaidi J, Barber J, Kyei-Mensah A, Bekir J, Campbell S and Tan SL (1996) Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 88,779-784.